Related Experiment Videos

Endothelial toxicity of ceftazidime in anterior chamber irrigation solution

A M Duch-Samper1, C Capdevila, J L Menezo

  • 1Service of Ophthalmology, Arnau de Vilanova Hospital, Valencia, Spain.

Experimental Eye Research
|December 1, 1996
PubMed

Insights

Ceftazidime concentrations above 3 mg/ml in intraocular infusions cause endothelial cell toxicity. This study determined safe ceftazidime levels for anterior chamber irrigation, finding higher doses harmful to ocular tissues.

Area of Science:

  • Ophthalmology
  • Pharmacology
  • Cell Biology

Background:

  • Aminoglycoside antibiotics carry high toxicity risks for intraocular infections.
  • Third-generation cephalosporins are often preferred for prophylaxis and treatment of intraocular infections.

Purpose of the Study:

  • To determine safe ceftazidime concentrations in anterior chamber irrigation solutions.
  • To assess the toxic effects of varying ceftazidime concentrations on ocular endothelial cells.

Main Methods:

  • New Zealand rabbits (n=12) underwent bilateral paracentesis.
  • Eyes were irrigated with BSS-Plus (BSS+) containing ceftazidime at concentrations of 2, 3, 4, 6, and 8 mg/ml.
  • Endothelial lesions were evaluated using silver nitrate staining to assess silver affinity.

Main Results:

  • Endothelial cell silver affinity increased with ceftazidime concentration.
  • Significant increases in 3-4+ silver affinity were observed at concentrations above 3 mg/ml.
  • Ceftazidime concentrations exceeding 3 mg/ml induced endothelial cell alterations and signs of attempted repair.

Conclusions:

  • Ceftazidime concentrations above 3 mg/ml in intraocular infusions are toxic to endothelial cells.
  • Lower concentrations may be safer for intraocular use, but further research is needed.
  • These findings guide the safe use of ceftazidime in ophthalmic irrigation solutions.

Related Concept Videos